WallStreetZenWallStreetZen

NASDAQ: PBYI
Puma Biotechnology Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Puma Biotechnology revenue was $212.00M for the trailing 12 months ending Sep 30, 2025, with 56.3% growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $54.5M, up 3.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PBYI annual revenue was $230.5M, with -2.2% growth year-over-year.

PBYI past revenue growth

How has PBYI's revenue growth performed historically?

Company
-12.96%
Industry
294.85%
Market
20.69%
PBYI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PBYI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PBYI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PBYI revenue history

Current Revenue
$212.0M
Current Earnings
$37.0M
Current Profit Margin
17.4%

Be the first to know when PBYI announces revenue.

PBYI Revenue History By Year

PBYI Yearly RevenuePBYI RevenuePBYI ChangePBYI Revenue Growth
2024-12-31$230.47M-$5.17M-2.19%
2023-12-31$235.64M$7.61M+3.34%
2022-12-31$228.03M-$25.12M-9.92%
2021-12-31$253.16M$28.05M+12.46%
2020-12-31$225.11M-$47.15M-17.32%
2019-12-31$272.26M$21.27M+8.47%
2018-12-31$250.99M$223.31M+806.60%
2017-12-31$27.69MN/AN/A
2016-12-31$0.00N/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A
2012-12-31$0.00N/AN/A
2011-12-31$0.00N/AN/A
2010-12-31$0.00N/AN/A
2009-12-31$0.00N/AN/A
2008-12-31$0.00N/AN/A
2007-12-31$0.00N/AN/A

1 of 2

Puma Biotechnology Revenue FAQ

What was PBYI's revenue last quarter?

On Invalid Date, Puma Biotechnology (NASDAQ: PBYI) reported Q3 2025 revenue of $54.48 million up 32.36% year over year. In the same quarter last year, Puma Biotechnology's revenue was $80.54 million.

What was Puma Biotechnology's revenue in 2024?

Puma Biotechnology's annual revenue for the twelve months ending Dec 31, 2024 was $230.47 million, a 2.19% decrease year over year.

How much does Puma Biotechnology make in a day?

Based on Puma Biotechnology annual revenue for the past five years, PBYI makes an average of $642,411.51 per day.

What was Puma Biotechnology's annual revenue growth in the past year?

As of Q4 2025, Puma Biotechnology's revenue has grown -12.96% year over year. This is 307.81 percentage points lower than the US Biotechnology industry revenue growth rate of 294.85%. Puma Biotechnology's revenue in the past year totaled $212.00 million.

How much does Puma Biotechnology make in a year?

Puma Biotechnology's revenue by year for the past five years is:
  • Puma Biotechnology's revenue for the twelve months ending Dec 31, 2024 was $230.47 million, a 2.19% decrease year over year.
  • Puma Biotechnology's annual revenue for Dec 31, 2023 was $235.64 million, a 3.34% increase from 2022.
  • Puma Biotechnology's annual revenue for 2022 was $228.03 million, a 9.92% decrease from 2021.
  • Puma Biotechnology's annual revenue for 2021 was $253.16 million, a 12.46% increase from 2020.
  • Puma Biotechnology's annual revenue for 2020 was $225.11 million, a 17.32% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.